What the Law and Bioethics Tell Us About Synthetic Human Embryos
By Barbara Pfeffer Billauer,
Bill of Health
| 10. 13. 2023
A synthetic embryo can now be constructed from very early pre-embryonic cells – without the need for an egg or sperm. These were initially created in mice. In April, researchers in China published about their creation of synthetic monkey embryos. In June, it was reported that the first synthetic human models were apparently created. This development throws a moral monkey-wrench into the current moratoria on embryonic research after 14 days. But there are more problems ahead.
Two weeks – the 14-day Rule
Of immediate concern are the ramifications of the 14-day rule, which imposes a (voluntary in the U.S.) moratorium on experimentation on human embryos older than 14 days; after that, they must be terminated. Strictly speaking, at this point, the fertilized egg (zygote) is called by various names, e.g., blastocyst and a “morula” (“little cherry”) because depending on the stage of development, that’s what the entity resembles. This zygote does not achieve full “embryo” status until day 14 after fertilization, the beginning of “gastrulation.”
In biological terms, the 15th day of embryo development is the point when...
Related Articles
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...